封面
市场调查报告书
商品编码
1593494

电子处方笺市场规模、份额和成长分析(按产品/服务、按交付方式、按物质、按应用、按最终用户、按地区):行业预测 (2024-2031)

E-Prescribing Market Size, Share, Growth Analysis, By Product & Service (Solutions, Services), By Delivery Mode (Web- & Cloud-Based Solutions, On-Premises Solutions), By Substances, By Usage, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 178 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球电子处方笺市场规模为21亿美元,从2023年的25.9亿美元成长到2031年的139.3亿美元,在预测期内(2024-2031年)预计复合年增长率为23.40。

由于 EPSC(受管制物质电子处方笺)的日益普及和有利的政府政策,全球电子处方笺市场正在显着增长。此外,病患安全意识的增强正在刺激市场扩张。 COVID-19 大流行加速了电子处方笺的采用,因为医疗机构寻求最大限度降低感染风险的方法,并强调了更容易获得处方药的好处。电子处方笺允许医疗保健专业人员将处方笺直接发送到药房,将处方笺流程数位化,以提高准确性、减少错误并提高效率。它还可以与各种医疗保健系统无缝集成,促进及时获得药物并改善患者护理。这些因素共同推动了全球对电子处方笺解决方案的需求。

目录

介绍

  • 分析目的
  • 定义
  • 市场范围

分析方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况及展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 监管环境
  • 案例研究分析
  • 技术分析

电子处方笺市场:依产品/服务分类

  • 市场概况
  • 解决方案
    • 综合解决方案
    • 独立解决方案
  • 服务
    • 支援和维护服务
    • 实施服务
    • 网路服务
    • 培训和教育服务

电子处方笺市场:以配送方式分类

  • 市场概况
  • 云端基础的解决方案
  • 本地解决方案

电子处方笺市场:依物质分类

  • 市场概况
  • 管制物质
  • 不受管制的物质

电子处方笺市场:按应用划分

  • 市场概况
  • 手持装置
  • 基于计算机的设备

电子处方笺市场:依最终用户分类

  • 市场概况
  • 医院
  • 在诊所工作的医生
  • 药局

电子处方笺市场:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲 (MEA)
    • 波湾合作理事会(GCC) 国家
    • 南非
    • 其他中东/非洲

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • Epic系统公司(美国)
  • Surescripts-Rxhub, LLC(美国)
  • 亨利沙因公司(美国)
  • DRFIRST, Inc.(美国)
  • DrChrono(美国)
  • MDToolbox(美国)
  • eClinicalWorks(美国)
  • 復兴健康(美国)
  • Moderna Therapeutics(美国)
  • MediMobile(美国)
  • ePrescribeRx(美国)
  • 健康波(美国)
  • RxNT(美国)
  • DrChrono(美国)
  • MediLedger 网路(美国)
  • Sunknowledge 服务公司(美国)
  • PointClickCare(加拿大)
  • RxVantage(美国)
简介目录
Product Code: SQMIG35F2016

Global E-Prescribing Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.59 billion in 2023 to USD 13.93 billion by 2031, growing at a CAGR of 23.40% during the forecast period (2024-2031).

The global e-prescribing market is experiencing significant growth, driven by the rising adoption of electronic prescribing for controlled substances (EPSC) and favorable government policies. Additionally, growing awareness of patient safety is further fueling market expansion. The COVID-19 pandemic accelerated the adoption of e-prescribing as healthcare facilities sought ways to minimize infection risks, highlighting the benefits of easier access to prescription medications. E-prescribing, which enables medical professionals to send prescriptions directly to pharmacies, improves accuracy, reduces errors, and enhances efficiency by digitizing the prescription process. It also ensures seamless integration with various medical systems, facilitating timely medication access and improving patient care. These factors collectively contribute to the growing demand for e-prescribing solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescribing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global E-Prescribing Market Segmental Analysis

Global E-Prescribing Market is segmented by Product & Service, Delivery Mode, Substances, Usage, End User, and Region. Based on Product & Service, the market is segmented into Solutions, and Services. Based on Delivery Mode, the market is segmented into Web- & Cloud-Based Solutions, and On-Premises Solutions. Based on Substances, the market is segmented into Controlled Substances, and Non-Controlled Substances. Based on Usage, the market is segmented into Handheld Devices, and Computer-Based Devices. Based on End User, the market is segmented into Hospitals, Office-Based Physicians, and Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global E-Prescribing Market

The growing government support for the adoption of Electronic Health Record (EHR) solutions, combined with the rising need to manage escalating healthcare costs, is a key driver for the global E-Prescribing market. The integration of EHR systems has significantly improved prescription management by enhancing the accessibility of patient medical histories, offering more comprehensive data than standalone e-prescribing systems. This seamless flow of information has streamlined the prescription process, boosting efficiency and reducing errors. As a result, there is an increasing demand for e-prescribing solutions that can leverage EHR systems to improve patient care and optimize healthcare workflows, further driving market growth.

Restraints in the Global E-Prescribing Market

One of the primary restraints hindering the growth of the global E-Prescribing market is the high cost associated with the implementation and maintenance of e-prescribing systems integrated with Electronic Health Records (EHR). The expense involved in adopting such solutions poses a significant challenge, particularly in developing economies where budget constraints and limited healthcare IT infrastructure further impede adoption. These regions struggle to implement advanced technological solutions due to the financial burden and lack of adequate support, preventing the widespread adoption of e-prescribing systems. As a result, the growth of the market is slowed, especially in emerging economies that face these infrastructural and economic challenges.

Market Trends of the Global E-Prescribing Market

One of the key trends driving the growth of the global e-prescribing market is the increasing opioid crisis in the United States. The e-prescribing of controlled substances (EPCS) system provides a secure and transparent solution, reducing the potential for misuse and fraud. By implementing electronic prescriptions for controlled medications, healthcare providers can more easily and safely prescribe necessary drugs to patients who genuinely need them, while simultaneously mitigating the risks associated with prescription drug abuse. This shift towards digital prescriptions is seen as an effective strategy to combat the opioid epidemic, promoting both patient safety and regulatory compliance, thus accelerating the adoption of e-prescribing technologies across the healthcare sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Case Study Analysis
  • Technology Analysis

E-Prescribing Market by Product & Service

  • Market Overview
  • Solutions
    • Integrated Solutions
    • Standalone Solutions
  • Services
    • Support & Maintenance Services
    • Implementation Services
    • Network Services
    • Training & Education Services

E-Prescribing Market by Delivery Mode

  • Market Overview
  • Web- & Cloud-Based Solutions
  • On-Premises Solutions

E-Prescribing Market by Substances

  • Market Overview
  • Controlled Substances
  • Non-Controlled Substances

E-Prescribing Market by Usage

  • Market Overview
  • Handheld Devices
  • Computer-Based Devices

E-Prescribing Market by End User

  • Market Overview
  • Hospitals
  • Office-Based Physicians
  • Pharmacies

E-Prescribing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Epic Systems Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surescripts-Rxhub, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Henry Schein, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DRFIRST, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DrChrono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MDToolbox (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eClinicalWorks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Renaissance Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moderna Therapeutics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MediMobile (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ePrescribeRx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthWave (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RxNT (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DrChrono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MediLedger Network (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sunknowledge Services Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PointClickCare (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RxVantage (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments